title: [Clinicopathological study of incidental cancer prostate in patients undergoing surgery for symptomatic diagnosis of BPH].
abstract: OBJECTIVES-INTRODUCTION: Retrospective study of a series of patients with prostate surgery (suprapubic prostate adenomectomy -APS-, and prostate transurethral resection -RTU-P-) for presumed BPH symptomatic non-respondent to the conservative medical treatment. Analysis of prevalence, incidence, clinical-pathological, treatment, tumor progression and evolution of the patients with incidental prostate cancer (CPI) detected.
  
  
  METHODS
  1593 patients with prostate surgery (APS and RTU-P) during 6 years (1996-2001) were revised. APS 35%, RTU-P 65%. Revision of all pathological anatomy of surgical specimens and the evolutions of the patients with CPI.
  
  
  RESULTS
  78 CPI; Prevalence 4,89%; Incidence 13 cases/year. Mean age 73.6 years. Digital rectal examination was normal in 100%, mean PSA 6 ng/ml (0.5-30). Group APS: 25 CPI (32%); prevalence 4.55%; incidence 4 cases/year; mean PSA 7.7 ng/ml (2.8-30); mean weight resection 65 gs. Group RTU-P: 53 CPI (68%); prevalence 5,07%; incidence 9 cases/year; mean PSA 5.2 ng/ml (0,5-29); mean weight resection 20 gs. 22% biopsy previously by high PSA, mean PSA 14 ng/ml (4,8-30). Gleason average 5 (mean 4.8), rank 3-8. pTla 66%, pTlb 33%.
  
  
  METHODS
  57% follow-up watched without treatment (wait and see); 18% hormonal treatment; 3% finasteride; 9% Radical Prostatectomy; 9% radiotherapy. Follow Lost 4%. Mean follow-up 47.19 months (12-96). Tumor progression 13.3% (10 patients). Specific CPI mortality 2.6% (2 patients).
  
  
  CONCLUSIONS
  We didn't observe significant differences between the prevalence of CPI in both groups (APS and RTU-P). The detected tumours were mainly well differentiated and in stage pTla. In more than half of the cases an expectant attitude without treatment was decided. 13,3% of tumor progression after 47.19 months of follow mean and specific CPI mortality 2.6%.
authors.affiliation: Servicio de Urología, Complejo Hospitalario Universitario Juan Canalejo, La Coruña. efrosado@ozu.es
authors.forename: E
authors.initials: E
authors.lastname: Fernández Rosado
authors.forename: F
authors.initials: F
authors.lastname: Gómez Veiga
authors.forename: L
authors.initials: L
authors.lastname: Alvarez Castelo
authors.forename: M
authors.initials: M
authors.lastname: Ruibal Moldes
authors.forename: V
authors.initials: V
authors.lastname: Chantada Abal
authors.forename: M
authors.initials: M
authors.lastname: González Martín
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D033162:Incidental Findings; D007432:Intraoperative Period; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications / Q000601:surgery*; D011471:Prostatic Neoplasms / Q000150:complications / Q000175:diagnosis*; D012189:Retrospective Studies